Blog

July 27, 2015 HEALTH (MSM)

Teva to buy Allergan generic drug business for $40.5 billion, drops Mylan bid

By Tova Cohen and Steven Scheer TEL AVIV (Reuters) – Teva Pharmaceutical Industries has agreed to buy Allergan Plc’s generic drugs business for $40.5 billion in a cash and stock deal that will turn the Israeli company into one of the world’s largest pharmaceutical firms. The deal, the largest in Israel’s corporate history, prompted Teva to drop its $40 billion hostile bid for Mylan, which used a poison pill-style defense

July 27, 2015 HEALTH (MSM)

Bellerophon shares plummet after heart drug fails in study

Bellerophon Therapeutics Inc’s shares plummeted more than 60 percent on Monday after the company said an injectable heart drug it is developing under license failed in a study. The drug, bioabsorbable cardiac matrix, was licensed from BioLineRx Ltd in 2009 after animal studies showed that it acted as a “scaffold” to support the heart wall and was likely to prevent further structural damage. When BCM is administered after a heart

July 27, 2015 HEALTH (MSM)

UK checking two suspected MERS cases in northern England

Two suspected cases of the Middle Eastern Respiratory Virus Syndrome (MERS) have forced a hospital in northern England to shut its emergency department, health officials said on Monday. Two patients at Manchester Royal Infirmary were placed in isolation, but there was no significant risk to others at the hospital or to the general public, Central Manchester University Hospitals Trust said. “Manchester Royal Infirmary Accident and Emergency Department will be closed